Sweden Cervical Cancer Diagnostic Market Size & Outlook
Sweden cervical cancer diagnostic market, 2018-2030 (US$M)
Related Markets
Sweden cervical cancer diagnostic market highlights
- The Sweden cervical cancer diagnostic market generated a revenue of USD 47.8 million in 2023 and is expected to reach USD 67.0 million by 2030.
- The Sweden market is expected to grow at a CAGR of 5% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
Cervical cancer diagnostic market data book summary
| Market revenue in 2023 | USD 47.8 million |
| Market revenue in 2030 | USD 67.0 million |
| Growth rate | 5% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Home Care |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
| Key market players worldwide | Abbott Laboratories, Qiagen NV, Thermo Fisher Scientific Inc, Carl Zeiss Meditec AG, Becton Dickinson & Co, Hologic Inc, CooperSurgical, Siemens Healthineers AG ADR |
Other key industry trends
- In terms of revenue, Sweden accounted for 1.1% of the global cervical cancer diagnostic market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany cervical cancer diagnostic market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 247.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cervical Cancer Diagnostic Market Scope
Cervical Cancer Diagnostic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Sweden cervical cancer diagnostic market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cervical cancer diagnostic market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 60.25% in 2023. Horizon Databook has segmented the Sweden cervical cancer diagnostic market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
- Sweden Cervical Cancer Diagnostic End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Outpatient Facilities
- Home Care
- Research & Manufacturing
Reasons to subscribe to Sweden cervical cancer diagnostic market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sweden cervical cancer diagnostic market databook
-
Our clientele includes a mix of cervical cancer diagnostic market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden cervical cancer diagnostic market , including forecasts for subscribers. This country databook contains high-level insights into Sweden cervical cancer diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Sweden cervical cancer diagnostic market size, by end use, 2018-2030 (US$M)
Sweden Cervical Cancer Diagnostic Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
